– GEN’s Editor-in-Chief John Sterling talks with Dr Andrew Maynard, Chief Science Advisor to the Project on Emerging Nanotechnologies.

Previous articleGSK Receives $63M HHS Contract for Flu Vaccine R&D
Next articleNicOx Achieves First Milestone of Euro 5M From Merck